The trademark application VecPharm was filed by CELLULAR BIOMEDICINE GROUP, INC, a U.S. corporation (the "Applicant"). The application was published for oppositions on May 11, 2020, and it was registered by office on August 18, 2020 without any oppositions.
The application was filed in English (French was selected as the second language).
Appointment and Replacement of representative of the trademark registration was recorded on April 21, 2020. Appointment and Replacement of representative of the trademark registration was recorded on December 15, 2022. A transfer of the trademark registration was recorded on December 22, 2022.
Goods And Services
The mark was filed in class 5 with following description of goods:
Cell growth media for growing cells for medical or clinical use
Cells for medical or clinical use
Solutions for medical and clinical use in storing and treating cells,blood and blood components
Synthetic cholesterol mainly for use in growing cell cultures
Biological tissue cultures for medical purposes
Clinical medical reagents for use in gene therapy
Pharmaceutical preparations for use in gene therapy
Retroviral vector preparations for use in gene therapy
Pharmaceutical preparations containing a retroviral vector delivering genes to cells for use in the treatment of viral and bacterial infections, cancer,leukemia and bodily conditions associated with impaired immuno systems.